SG74074A1 - Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa - Google Patents
Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoaInfo
- Publication number
- SG74074A1 SG74074A1 SG1998003335A SG1998003335A SG74074A1 SG 74074 A1 SG74074 A1 SG 74074A1 SG 1998003335 A SG1998003335 A SG 1998003335A SG 1998003335 A SG1998003335 A SG 1998003335A SG 74074 A1 SG74074 A1 SG 74074A1
- Authority
- SG
- Singapore
- Prior art keywords
- protozoa
- disorders
- inhibitors
- pharmaceutical
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19737463A DE19737463A1 (de) | 1997-08-28 | 1997-08-28 | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
Publications (1)
Publication Number | Publication Date |
---|---|
SG74074A1 true SG74074A1 (en) | 2000-07-18 |
Family
ID=7840411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1998003335A SG74074A1 (en) | 1997-08-28 | 1998-08-27 | Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
Country Status (26)
Country | Link |
---|---|
US (1) | US6114393A (ko) |
EP (1) | EP0901788A3 (ko) |
JP (1) | JPH11171792A (ko) |
KR (1) | KR100567144B1 (ko) |
CN (1) | CN1244322C (ko) |
AR (1) | AR013949A1 (ko) |
AU (1) | AU738599B2 (ko) |
BR (1) | BR9803243A (ko) |
CA (1) | CA2246407A1 (ko) |
CZ (1) | CZ296815B6 (ko) |
DE (1) | DE19737463A1 (ko) |
HK (1) | HK1018589A1 (ko) |
HR (1) | HRP980468A2 (ko) |
HU (1) | HU225583B1 (ko) |
ID (1) | ID20794A (ko) |
IL (1) | IL125946A0 (ko) |
MY (1) | MY137406A (ko) |
NO (1) | NO320368B1 (ko) |
NZ (1) | NZ331566A (ko) |
PL (1) | PL191267B1 (ko) |
RU (1) | RU2225726C2 (ko) |
SG (1) | SG74074A1 (ko) |
SK (1) | SK285457B6 (ko) |
TR (1) | TR199801669A2 (ko) |
TW (1) | TW592690B (ko) |
ZA (1) | ZA987781B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
CA2395333C (en) * | 1999-12-23 | 2009-01-13 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
US7375138B2 (en) | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
US6878748B2 (en) | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
LT3649109T (lt) * | 2017-07-04 | 2021-09-27 | Sanofi | Etinilo junginiai, jų gamyba ir jų terapinis panaudojimas maliarijos gydymui |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1336871A (en) * | 1970-01-02 | 1973-11-14 | Wellcome Found | Method for preparing biologically active substituted amidines |
US4088780A (en) * | 1974-05-15 | 1978-05-09 | Bayer Aktiengesellschaft | Substituted phenylguanidines and processes for their preparation and use |
US4032655A (en) * | 1974-05-15 | 1977-06-28 | Bayer Aktiengesellschaft | Phenylguanidines useful as anthelmintic agents |
US4544670A (en) * | 1982-08-24 | 1985-10-01 | William H. Rorer, Inc. | Method of treating coccidiosis with acyl guanidines |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
IN172842B (ko) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
US5352667A (en) * | 1991-11-22 | 1994-10-04 | Ofer Lider | Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them |
CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19502644A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | 4-Amino-benzoylguanidin-Derivate |
FR2734263B1 (fr) * | 1995-05-17 | 1997-06-20 | Fournier Ind & Sante | Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique |
CA2223910C (en) * | 1995-06-07 | 2008-09-16 | Magainin Pharmaceuticals Inc. | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1997
- 1997-08-28 DE DE19737463A patent/DE19737463A1/de not_active Withdrawn
-
1998
- 1998-08-24 EP EP98115902A patent/EP0901788A3/de not_active Withdrawn
- 1998-08-26 IL IL12594698A patent/IL125946A0/xx not_active IP Right Cessation
- 1998-08-26 ID IDP981166A patent/ID20794A/id unknown
- 1998-08-26 HU HU9801925A patent/HU225583B1/hu not_active IP Right Cessation
- 1998-08-26 AR ARP980104256A patent/AR013949A1/es unknown
- 1998-08-26 TR TR1998/01669A patent/TR199801669A2/xx unknown
- 1998-08-26 US US09/140,544 patent/US6114393A/en not_active Expired - Fee Related
- 1998-08-26 NZ NZ331566A patent/NZ331566A/en unknown
- 1998-08-26 CA CA002246407A patent/CA2246407A1/en not_active Abandoned
- 1998-08-26 SK SK1174-98A patent/SK285457B6/sk unknown
- 1998-08-26 CZ CZ0272998A patent/CZ296815B6/cs not_active IP Right Cessation
- 1998-08-27 RU RU98116380/15A patent/RU2225726C2/ru not_active IP Right Cessation
- 1998-08-27 CN CNB981184928A patent/CN1244322C/zh not_active Expired - Fee Related
- 1998-08-27 MY MYPI98003946A patent/MY137406A/en unknown
- 1998-08-27 HR HR19737463.8A patent/HRP980468A2/hr not_active Application Discontinuation
- 1998-08-27 NO NO19983943A patent/NO320368B1/no unknown
- 1998-08-27 ZA ZA987781A patent/ZA987781B/xx unknown
- 1998-08-27 KR KR1019980034759A patent/KR100567144B1/ko not_active IP Right Cessation
- 1998-08-27 AU AU81894/98A patent/AU738599B2/en not_active Ceased
- 1998-08-27 SG SG1998003335A patent/SG74074A1/en unknown
- 1998-08-27 JP JP10241376A patent/JPH11171792A/ja not_active Abandoned
- 1998-08-27 BR BR9803243A patent/BR9803243A/pt not_active Application Discontinuation
- 1998-08-28 PL PL328265A patent/PL191267B1/pl not_active IP Right Cessation
- 1998-09-23 TW TW087114024A patent/TW592690B/zh not_active IP Right Cessation
-
1999
- 1999-07-28 HK HK99103255A patent/HK1018589A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU0003863D0 (en) | Alpha-sulfonylamino hidroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders | |
PL350050A1 (en) | Acyl derivatives which treat vla-4 related disorders | |
HUP0001777A3 (en) | Use of cyclooxygenase-2 inhibitors for producing medicaments useful for the prevention of cardiovascular disorders | |
ID28529A (id) | Vinileter heterosiklik untuk gangguan neurologi | |
NO20004688D0 (no) | Terapi ved østrogenassosierte lidelser | |
GB0010669D0 (en) | Compositions for treatment of disorders of the oesophagus | |
IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
ZA9810218B (en) | Isoquinoline derivatives for use against cns disorders | |
ZA987500B (en) | Process for the production of aromatic amines | |
ZA987781B (en) | Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa | |
PT1294710E (pt) | Derivados de indole uteis para o tratamento de disturbios do snc | |
FR2777560B1 (fr) | Procede de purification de polyamines aromatiques | |
CZ20011872A3 (cs) | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny | |
IL126068A0 (en) | The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart | |
PL346842A1 (en) | New pharmaceutical uses for nos inhibitors | |
IL126276A0 (en) | The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system | |
HK1040933A1 (zh) | N-取代的氮雜二環烷衍生物在治療中樞神經系統疾病中的應用 | |
ZA988729B (en) | The use of an inhibitor of the Na/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system | |
FR2770214B1 (fr) | Procede de preparation d'un benzamide halogene | |
EP1178814A4 (en) | METHOD OF IDENTIFYING THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF HEPATIC DISORDERS | |
FR2765576B1 (fr) | Procede de preparation des dinitroanilines 4-substituees | |
FR2761685B1 (fr) | Procede de preparation des dinitroanilines 4-substituees | |
PT102299B (pt) | Processo metalurgico para a utilizacao de minerais piriticos polimetalicos | |
FR2802924B1 (fr) | Procede de preparation des 6-halogeno-2-chloroquinoxalines | |
FR2760011B1 (fr) | Procede de preparation de 3-chloromethyl-3-alkyloxethane |